BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10215770)

  • 1. Soluble E-selectin and eosinophil cationic protein are distinct serum markers that differentially represent clinical features of atopic dermatitis.
    Furue M; Koga T; Yamashita N
    Br J Dermatol; 1999 Jan; 140(1):67-72. PubMed ID: 10215770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of serum-soluble E-selectin in atopic dermatitis.
    Morita H; Kitano Y; Kawasaki N
    J Dermatol Sci; 1995 Sep; 10(2):145-50. PubMed ID: 8534613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis.
    Wolkerstorfer A; Laan MP; Savelkoul HF; Neijens HJ; Mulder PG; Oudesluys-Murphy AM; Sukhai RN; Oranje AP
    Br J Dermatol; 1998 Mar; 138(3):431-5. PubMed ID: 9580795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis.
    Miyasato M; Tsuda S; Nakama T; Kato K; Kitamura N; Nagaji J; Sasai Y
    J Dermatol; 1996 Jun; 23(6):382-8. PubMed ID: 8708149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
    Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
    J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.
    Pucci N; Lombardi E; Novembre E; Farina S; Bernardini R; Rossi E; Favilli T; Vierucci A
    J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
    Tsuda S; Kato K; Miyasato M; Sasai Y
    J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
    Czech W; Krutmann J; Schöpf E; Kapp A
    Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
    Kägi MK; Joller-Jemelka H; Wüthrich B
    Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores.
    Gutgesell C; Heise S; Seubert A; Stichtenoth DO; Frölich JC; Neumann C
    Br J Dermatol; 2002 Nov; 147(5):914-9. PubMed ID: 12410700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein.
    Taniuchi S; Chihara J; Kojima T; Yamamoto A; Sasai M; Kobayashi Y
    J Dermatol Sci; 2001 May; 26(1):79-82. PubMed ID: 11323224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between eosinophil-associated parameters and disease severity in atopic dermatitis.
    Nakama T
    Kurume Med J; 1995; 42(2):95-106. PubMed ID: 7564170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum eosinophil cationic protein in patients with atopic dermatitis.
    Paganelli R; Fanales-Belasio E; Carmini D; Scala E; Meglio P; Businco L; Aiuti F
    Int Arch Allergy Appl Immunol; 1991; 96(2):175-8. PubMed ID: 1769747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
    Wüthrich B; Kägi MK; Joller-Jemelka H
    Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases.
    Kim TY; Park HJ; Kim CW
    J Dermatol Sci; 1997 Aug; 15(2):89-94. PubMed ID: 9279689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophil cationic protein, myeloperoxidase and tryptase in children with asthma and atopic dermatitis.
    Kristjánsson S; Shimizu T; Strannegård IL; Wennergren G
    Pediatr Allergy Immunol; 1994 Nov; 5(4):223-9. PubMed ID: 7894629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific IgE antibodies and serum eosinophil cationic protein in children with atopic dermatitis alone.
    Urisu A; Kondo Y; Wada E; Horiba F; Tsuruta M; Yasaki T
    Acta Paediatr Jpn; 1994 Apr; 36(2):146-9. PubMed ID: 8203257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of serologic immune parameters in inflammatory skin diseases.
    Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
    Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
    Nishimoto M; Numahara T; Nakashima K; Yoshida T
    Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.